X
Search Filters
Format Format
Subjects Subjects
Subjects Subjects
X
Sort by Item Count (A-Z)
Filter by Count
index medicus (603) 603
humans (577) 577
female (351) 351
male (332) 332
middle aged (268) 268
surgery (262) 262
aged (230) 230
adult (220) 220
infectious diseases (200) 200
risk factors (158) 158
intraabdominal infections (156) 156
microbiology (153) 153
retrospective studies (153) 153
anti-bacterial agents - therapeutic use (140) 140
mortality (133) 133
epidemiology (132) 132
health aspects (125) 125
treatment outcome (124) 124
management (123) 123
pharmacology & pharmacy (108) 108
antibiotics (103) 103
aged, 80 and over (101) 101
medicine & public health (97) 97
microbial sensitivity tests (95) 95
anti-bacterial agents - pharmacology (94) 94
risk-factors (91) 91
abdomen (89) 89
adolescent (89) 89
intraabdominal infections - microbiology (89) 89
analysis (87) 87
prospective studies (86) 86
sepsis (86) 86
infections (82) 82
intraabdominal infections - drug therapy (79) 79
complicated intraabdominal infections (78) 78
intraabdominal infections - epidemiology (78) 78
postoperative complications - epidemiology (78) 78
peritonitis (75) 75
young adult (73) 73
incidence (72) 72
care and treatment (69) 69
research (68) 68
abridged index medicus (67) 67
prognosis (62) 62
drug resistance (59) 59
escherichia-coli (59) 59
child (58) 58
gastroenterology & hepatology (58) 58
enterobacteriaceae (57) 57
hospitals (57) 57
klebsiella-pneumoniae (57) 57
diagnosis (54) 54
drug resistance, bacterial (54) 54
bacteria (53) 53
critical care medicine (53) 53
critically-ill patients (52) 52
guidelines (49) 49
intensive care units (49) 49
internal medicine (49) 49
infectious disease (46) 46
intensive-care-unit (46) 46
time factors (46) 46
double-blind (45) 45
prevalence (45) 45
septic shock (45) 45
therapy (45) 45
patients (44) 44
appendicitis (42) 42
children (42) 42
drug resistance in microorganisms (42) 42
pediatrics (42) 42
abdominal surgery (41) 41
outcomes (41) 41
abscess (40) 40
cross infection - microbiology (40) 40
intra-abdominal infection (40) 40
pneumonia (40) 40
susceptibility (40) 40
antimicrobial agents (39) 39
antimicrobial resistance (39) 39
intraabdominal infection (39) 39
child, preschool (38) 38
gram-negative bacilli (38) 38
intraabdominal hypertension (38) 38
medicine, general & internal (38) 38
nosocomial infections (38) 38
pseudomonas-aeruginosa (38) 38
bacterial infections - drug therapy (37) 37
enterobacteriaceae - drug effects (37) 37
gram-negative bacteria (37) 37
intensive care (37) 37
medical research (37) 37
multivariate analysis (37) 37
appendicitis - surgery (36) 36
in-vitro activity (36) 36
prevention (36) 36
antibiotic-therapy (35) 35
blood-stream infections (35) 35
complications (35) 35
drug resistance, multiple, bacterial (35) 35
more...
Language Language
Language Language
X
Sort by Item Count (A-Z)
Filter by Count
English (669) 669
Spanish (11) 11
German (5) 5
French (4) 4
Chinese (3) 3
Hungarian (1) 1
Russian (1) 1
Swedish (1) 1
more...
Publication Date Publication Date
Click on a bar to filter by decade
Slide to change publication date range


Antimicrobial Agents and Chemotherapy, ISSN 0066-4804, 10/2016, Volume 60, Issue 10, pp. 6115 - 6120
Hypervirulent Klebsiella pneumoniae (hvKP) is traditionally defined by hypermucoviscosity, but data based on genetic background are limited.... 
STRAINS | AEROBACTIN | VIRULENCE ANALYSIS | TAIWAN | MICROBIOLOGY | PHARMACOLOGY & PHARMACY | SPECTRUM BETA-LACTAMASES | HONG-KONG | EMERGENCE | PYOGENIC LIVER-ABSCESS | Diabetes Mellitus - pathology | Prevalence | Prospective Studies | Klebsiella Infections - pathology | Humans | Middle Aged | Virulence | Male | Klebsiella pneumoniae - classification | Phylogeny | Multilocus Sequence Typing | Cross Infection - pathology | beta-Lactamases - genetics | Pneumonia, Bacterial - pathology | Gene Expression | Pneumonia, Bacterial - complications | Plasmids - metabolism | Cross Infection - microbiology | Diabetes Mellitus - epidemiology | Plasmids - chemistry | Bacteremia - epidemiology | Bacteremia - pathology | Neoplasms - epidemiology | Intraabdominal Infections - complications | Klebsiella pneumoniae - isolation & purification | Diabetes Complications | Cross Infection - complications | Bacteremia - microbiology | Neoplasms - complications | Klebsiella Infections - epidemiology | Klebsiella pneumoniae - genetics | Adult | Female | beta-Lactamases - metabolism | Cross Infection - epidemiology | Pneumonia, Bacterial - microbiology | Intraabdominal Infections - microbiology | Neoplasms - microbiology | Phylogeography | Bacteremia - complications | Bacterial Proteins - genetics | Serogroup | Klebsiella Infections - complications | Pneumonia, Bacterial - epidemiology | China - epidemiology | Klebsiella Infections - microbiology | Intraabdominal Infections - epidemiology | Diabetes Mellitus - microbiology | Intraabdominal Infections - pathology | Klebsiella pneumoniae - pathogenicity | Bacterial Proteins - metabolism | Aged | Neoplasms - pathology | Index Medicus
Journal Article
Journal Article
International Journal of Antimicrobial Agents, ISSN 0924-8579, 2012, Volume 40, Issue 1, pp. S37 - S43
Summary In 2009, the Study for Monitoring Antimicrobial Resistance Trends (SMART) was expanded to include surveillance of Gram-negative pathogens causing... 
Infectious Disease | Asia-Pacific region | Fluoroquinolone resistance | Urinary tract infections | Extended-spectrum β-lactamase (ESBL) | SMART | Carbapenems | Interpretive susceptibility criteria | INFECTIOUS DISEASES | RISK-FACTORS | MICROBIOLOGY | Extended-spectrum beta-lactamase (ESBL) | INTRAABDOMINAL INFECTIONS | PHARMACOLOGY & PHARMACY | BACILLI | Penicillanic Acid - pharmacology | Prevalence | Prospective Studies | Ceftazidime - pharmacology | Humans | Australasia - epidemiology | Drug Resistance, Bacterial | Amikacin - pharmacology | beta-Lactamases - biosynthesis | Gram-Negative Bacteria - isolation & purification | Gram-Negative Bacteria - enzymology | Gram-Negative Bacterial Infections - microbiology | Microbial Sensitivity Tests | Gram-Negative Bacteria - drug effects | Urinary Tract Infections - epidemiology | Asia - epidemiology | Piperacillin - pharmacology | beta-Lactams - pharmacology | Carbapenems - pharmacology | Gram-Negative Bacteria - pathogenicity | Gram-Negative Bacterial Infections - epidemiology | Urinary Tract Infections - microbiology | Anti-Bacterial Agents - pharmacology | Penicillanic Acid - analogs & derivatives | Moxalactam | Levofloxacin | Pneumonia | Bacterial pneumonia | Disease susceptibility | Antibacterial agents | Cephalosporins | Beta lactamases | Cephaloridine | Bacteria | Cross infection | Nosocomial infections | Ciprofloxacin | Health aspects | Index Medicus
Journal Article
International Journal of Antimicrobial Agents, ISSN 0924-8579, 2017, Volume 49, Issue 6, pp. 734 - 739
Journal Article
BMC Infectious Diseases, ISSN 1471-2334, 12/2014, Volume 14, Issue 1, pp. 659 - 659
Background: In order to investigate the epidemiology, molecular characteristics, and distribution of extended-spectrum beta-lactamase (ESBL)- and... 
SPECTRUM-BETA-LACTAMASE | ANTIMICROBIAL SUSCEPTIBILITY | MOLECULAR CHARACTERIZATION | UNITED-STATES | ACQUIRED INFECTIONS | INFECTIOUS DISEASES | URINARY-TRACT-INFECTIONS | EXTENDED-SPECTRUM | GENOTYPE DISTRIBUTION | INTRAABDOMINAL INFECTIONS | KLEBSIELLA-PNEUMONIAE | Prevalence | Community-Acquired Infections - epidemiology | Humans | Middle Aged | Male | Multilocus Sequence Typing | Young Adult | beta-Lactamases - genetics | Bacterial Typing Techniques | Polymerase Chain Reaction | Aged, 80 and over | Adult | DNA, Bacterial - analysis | Female | beta-Lactamases - metabolism | Escherichia coli - enzymology | Bacterial Proteins - genetics | Escherichia coli Infections - microbiology | Hospitals, County | Escherichia coli Proteins - metabolism | Genotype | China - epidemiology | Genetic Markers | Sequence Analysis, DNA | Escherichia coli Infections - epidemiology | Escherichia coli - genetics | Escherichia coli - isolation & purification | Adolescent | Escherichia coli Proteins - genetics | Bacterial Proteins - metabolism | Aged | Community-Acquired Infections - microbiology | Escherichia coli - classification | Hospitals | Escherichia coli | Beta lactamases | Cross infection | Nucleotide sequencing | Nosocomial infections | Health aspects | Epidemiology | Prevalence studies (Epidemiology) | DNA sequencing | Studies | Bacterial infections | Antibiotics | E coli | Laboratories | Antimicrobial agents | Drug resistance | Medical diagnosis | Bacteriology | Deoxyribonucleic acid--DNA | Index Medicus
Journal Article
Journal of Antimicrobial Chemotherapy, ISSN 0305-7453, 2017, Volume 72, Issue 5, pp. 1364 - 1372
Journal Article
Journal of Internal Medicine, ISSN 0954-6820, 06/2012, Volume 271, Issue 6, pp. 608 - 618
Schmidt M, Horvath‐Puho E, Thomsen RW, Smeeth L, Sørensen HT (Department of Clinical Epidemiology, Institute of Clinical Medicine, Aarhus University Hospital,... 
infections | deep venous thrombosis | pulmonary embolism | antibacterial agents | venous thromboembolism | Pulmonary embolism | Infections | Deep venous thrombosis | Antibacterial agents | Venous thromboembolism | CONTROLLED-TRIAL | HOSPITALIZED-PATIENTS | RISK-FACTORS | LOW-DOSE HEPARIN | FATAL PULMONARY-EMBOLISM | PREVENTION | DEEP-VEIN THROMBOSIS | MEDICINE, GENERAL & INTERNAL | INFARCTION | COMMUNITY | MEDICAL PATIENTS | Prevalence | Humans | Middle Aged | Male | Pulmonary Embolism - epidemiology | Urinary Tract Infections - complications | Case-Control Studies | Cross Infection - complications | Venous Thromboembolism - drug therapy | Incidence | Outpatients - statistics & numerical data | Anti-Bacterial Agents - therapeutic use | Bacterial Infections - complications | Pulmonary Embolism - microbiology | Skin Diseases, Bacterial - complications | Female | Community-Acquired Infections - complications | Respiratory Tract Infections - complications | Odds Ratio | Venous Thromboembolism - epidemiology | Bacterial Infections - microbiology | Venous Thromboembolism - diagnosis | Acute Disease | Risk Assessment | Bacterial Infections - drug therapy | Risk Factors | Bacteremia - complications | Medical Records | Logistic Models | Inpatients - statistics & numerical data | Cross Infection - drug therapy | Pulmonary Embolism - diagnosis | Algorithms | Bacterial Infections - epidemiology | Venous Thromboembolism - microbiology | Denmark - epidemiology | Pulmonary Embolism - drug therapy | Aged | Intraabdominal Infections - complications | Index Medicus | Original
Journal Article
Clinical infectious diseases, ISSN 1058-4838, 2015, Volume 61, Issue 9, pp. 1413 - 1420
Journal Article
Journal of Antimicrobial Chemotherapy, ISSN 0305-7453, 07/2013, Volume 68, Issue 2, pp. ii45 - ii55
Antimicrobial drug resistance is a growing problem in Europe and, even with differences in epidemiology, it is of great concern. The treatment of complicated... 
Complicated skin and soft-tissue infections | Complicated intra-abdominal infections | Non-interventional studies | Broad-spectrum antibacterial therapy | Polymicrobial infections | INFECTIOUS DISEASES | non-interventional studies | complicated skin and soft-tissue infections | ESCHERICHIA-COLI | MICROBIOLOGY | broad-spectrum antibacterial therapy | IN-VITRO SUSCEPTIBILITY | polymicrobial infections | complicated intra-abdominal infections | SEVERELY ILL PATIENTS | METALLO-BETA-LACTAMASE | SKIN-STRUCTURE INFECTIONS | INTENSIVE-CARE-UNIT | COMPLICATED INTRAABDOMINAL INFECTIONS | PHARMACOLOGY & PHARMACY | STAPHYLOCOCCUS-AUREUS | BLOOD-STREAM INFECTIONS | KLEBSIELLA-PNEUMONIAE | Skin Diseases, Bacterial - microbiology | Gram-Positive Bacteria - drug effects | Minocycline - pharmacology | Humans | Middle Aged | Minocycline - analogs & derivatives | Drug Resistance, Bacterial | Male | Skin Diseases, Bacterial - drug therapy | Gram-Negative Bacteria - isolation & purification | Anti-Bacterial Agents - therapeutic use | Skin Diseases, Bacterial - epidemiology | Minocycline - therapeutic use | Aged, 80 and over | Adult | Female | Soft Tissue Infections - drug therapy | Bacterial Infections - microbiology | Bacterial Infections - drug therapy | Intraabdominal Infections - microbiology | Europe | Treatment Outcome | Soft Tissue Infections - epidemiology | Intraabdominal Infections - epidemiology | Gram-Negative Bacteria - drug effects | Drug Therapy, Combination - methods | Soft Tissue Infections - microbiology | Bacterial Infections - epidemiology | Gram-Positive Bacteria - isolation & purification | Aged | Anti-Bacterial Agents - pharmacology | Intraabdominal Infections - drug therapy | Pathogens | Effectiveness | Antibiotics | Antimicrobial agents | Drug resistance | Drug therapy | Epidemiology | Index Medicus
Journal Article
Journal Article
Journal Article
Antimicrobial Agents and Chemotherapy, ISSN 0066-4804, 01/2016, Volume 60, Issue 1, pp. 245 - 251
Journal Article